CS logo
small CS logo
Klinikum der Universität München; Campus Großhadern; Med. Klinik und Poliklinik V

Munchen, Germany
University hospital in Munich, Bavaria
Marchioninistraße 15, 81377 München
1,940 Beds

About Klinikum der Universität München; Campus Großhadern; Med. Klinik und Poliklinik V


The Klinikum Großhadern of the Ludwig Maximilian University of Munich in the Großhadern district of Hadern is the largest hospital complex in Munich, owing to its affiliated institutions and 1,940 beds.
There are 1,940 beds in Klinikum der Universität München; Campus Großhadern; Med. Klinik und Poliklinik V.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
5
Pfizer
2
Total Rows: 2

Clinical Trials at Klinikum der Universität München; Campus Großhadern; Med. Klinik und Poliklinik V


During the past decade, Klinikum der Universität München; Campus Großhadern; Med. Klinik und Poliklinik V conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years111111000011001100000022Started TrialsCompleted Trails2015201620172018201920200123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene
2010-01-01
2015-12-01
Completed
1,069
An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene
2009-09-01
2016-01-01
Completed
347
Longitudinal Cohort Study in Participants With Severe Asthma to Assess Biomarkers
2015-08-28
2017-07-10
Completed
483
Evaluation of Long-Term Safety of Pirfenidone (Esbriet) in Participants With Idiopathic Pulmonary Fibrosis (IPF)
2012-02-16
2016-09-15
Completed
1,009
Efficacy, Safety, and Tolerability Study of Pirfenidone in Combination With Sildenafil in Participants With Advanced Idiopathic Pulmonary Fibrosis (IPF) and Intermediate or High Probability of Group 3 Pulmonary Hypertension
2016-12-31
2020-08-22
Completed
177
A Study of Pirfenidone in Patients With Unclassifiable Progressive Fibrosing Interstitial Lung Disease
2017-05-15
2020-01-10
Completed
253
A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)
2020-07-24
2026-06-25
Recruiting
226

Rows per page:

1–7 of 7

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 5Hoffmann-La Roche: 5Pfizer: 2Pfizer: 2

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Klinikum der Universität München; Campus Großhadern; Med. Klinik und Poliklinik V


According to Clinical.Site data, the most researched conditions in "Klinikum der Universität München; Campus Großhadern; Med. Klinik und Poliklinik V" are "Carcinoma, Non-Small-Cell Lung" (3 trials), "Idiopathic Pulmonary Fibrosis" (2 trials), "Adenocarcinoma" (1 trials), "Asthma" (1 trials) and "Bronchial Diseases" (1 trials). Many other conditions were trialed in "Klinikum der Universität München; Campus Großhadern; Med. Klinik und Poliklinik V" in a lesser frequency.

Clinical Trials Intervention Types at Klinikum der Universität München; Campus Großhadern; Med. Klinik und Poliklinik V


Most popular intervention types in "Klinikum der Universität München; Campus Großhadern; Med. Klinik und Poliklinik V" are "Drug" (7 trials). Other intervention types were less common.
The name of intervention was led by "Pirfenidone" (3 trials), "PF-02341066" (2 trials), "Pemetrexed" (2 trials), "Placebo" (2 trials) and "Carboplatin" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Klinikum der Universität München; Campus Großhadern; Med. Klinik und Poliklinik V


The vast majority of trials in "Klinikum der Universität München; Campus Großhadern; Med. Klinik und Poliklinik V" are 7 trials for "All" genders.

Clinical Trials Status at Klinikum der Universität München; Campus Großhadern; Med. Klinik und Poliklinik V


Currently, there are NaN active trials in "Klinikum der Universität München; Campus Großhadern; Med. Klinik und Poliklinik V". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Klinikum der Universität München; Campus Großhadern; Med. Klinik und Poliklinik V, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Klinikum der Universität München; Campus Großhadern; Med. Klinik und Poliklinik V, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 3Phase 2: 3Phase 3: 2Phase 3: 2Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 6Completed: 6Recruiting: 1Recruiting: 1